Indian American doctor Bags Pulitzer Prize 2011

By siliconindia   |   Tuesday, 19 April 2011, 20:23 IST   |    3 Comments
Printer Print Email Email
Indian American doctor  Bags Pulitzer Prize 2011
Boston: Indian American doctor Siddhartha Mukherjee's book on cancer "The Emperor of All Maladies: A Biography on Cancer" bags prestigious 2011 Pulitzer Prize. Mukherjee's book "The Emperor of All Maladies" revolves around history of diseases and how the doctors have fought against diseases since ages. A profoundly human biography on cancer has been presented by Dr Mukherjee which had its first documented appearance thousand years ago. The Pulitzer in the general non-fiction category accompanies $10,000. The Pulitzer award citation described The Emperor of All Maladies as "an elegant inquiry, at once clinical and personal, into the long history of an insidious disease that, despite treatment breakthroughs, still bedevils medical science". Dr Mukherjee was born in New Delhi, India. He went to school at St. Columba's School. He has been declared a Rhodes Scholar by University of Oxford which is world's most prestigious scholarship. He majored in biology from Stanford University and gratuated from Harvard Medical School. He is an assistant professor of medicine at Columbia University and a staff cancer physician at Columbia University Medical Centre. He has written articles for The New England Journal of Medicine, The New York Times and The Republic. The critically-acclaimed book has been described as a "literary thriller with cancer as the protagonist". The book provides an in depth study into the world of cancer and the various treatments. According to information about the book on the Pulitzer website the book talks about treatments ranging from the Persian Queen Atossa whose Greek slave cut off her malignant breast, to the 19th-century recipients of primitive radiation and chemotherapy to Mukherjee's own leukemia patient, Carla, The Emperor of All Maladies is about the people who have soldiered through fiercely demanding regimens in order to survive and to increase our understanding of this iconic disease.